NEU neuren pharmaceuticals limited

Ann: Trofinetide marketing application submitted in Europe, page-86

  1. 1,795 Posts.
    lightbulb Created with Sketch. 3221
    Providing details on any new indications not only informs the market, but it also informs potential competitors who may be considering product development for those indications.

    The later others know of Neuren’s intentions the better.

    Silence should allow NEU to have the advantage of first into relevant Phase 2 trials.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.